Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 48,408 |
|
|||||
| News | - | ||||||
| Day High | 25.61 | Low High |
|||||
| Day Low | 24.69 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mirum Pharmaceuticals Inc | MIRM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.34 | -1.35% | 24.77 | 10:08:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 25.02 | 24.69 | 25.61 | 25.11 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,052 | 48,408 | US$ 25.29 | US$ 1,224,296 | - | 23.14 - 35.56 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:09:20 | 4 | US$ 24.80 | USD |
Mirum Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.16B | 46.61M | - | 186.37M | -163.42M | -3.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mirum Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIRM Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.93 | 25.76 | 23.14 | 24.66 | 461,468 | -0.16 | -0.64% |
| 1 Month | 25.17 | 26.61 | 23.14 | 24.80 | 401,169 | -0.40 | -1.59% |
| 3 Months | 27.17 | 30.23 | 23.14 | 26.71 | 497,410 | -2.40 | -8.83% |
| 6 Months | 27.18 | 35.56 | 23.14 | 28.55 | 601,811 | -2.41 | -8.87% |
| 1 Year | 26.85 | 35.56 | 23.14 | 28.26 | 555,787 | -2.08 | -7.75% |
| 3 Years | 19.59 | 35.56 | 12.82 | 24.91 | 359,055 | 5.18 | 26.44% |
| 5 Years | 13.00 | 35.56 | 6.5126 | 23.55 | 279,603 | 11.77 | 90.54% |
Mirum Pharmaceuticals Description
| Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. |
